Idarubicin is superior to daunorubicin in remission induction ofde novoacute myeloid leukemia patients with highMDR1expression

Title
Idarubicin is superior to daunorubicin in remission induction ofde novoacute myeloid leukemia patients with highMDR1expression
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 14, Issue 1, Pages 17-23
Publisher
Future Medicine Ltd
Online
2012-12-20
DOI
10.2217/pgs.12.182

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation